Front Page VSPN Message Boards Chat Library Continual Education Search MyVSPN - Coming Soon Help Frequently Asked Questions Send us Feedback! Go to VIN Industry Partners Go to VetQuest Go to Veterinary Partner Go to Y2Spay
 
Menu bar   Go to the VIN.com Portal
 

ABSTRACT OF THE WEEK

Tierärztliche Praxis. Ausgabe K, Kleintiere/Heimtiere
Volume 48 | Issue 3 (June 2020)

Nasal transmissible venereal tumours in 12 dogs - a retrospective study.

Nasales Sticker-Sarkom bei 12 Hunden – eine retrospektive Studie.

Tierarztl Prax Ausg K Kleintiere Heimtiere. June 2020;48(3):164-170.

Nataliia Ignatenko1, Irina Abramenko2, Sara Soto3, Ralf Müeller4, Teresa M S A Boehm5, Karin Troedson6, Csilla Fejos7, Johannes Hirschberger8
1 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.; 2 Clinical Immunology Department, Research Center for Radiation Medicine.; 3 Institute of Animal Pathology, Vetsuisse Faculty, University of Berne.; 4 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.; 5 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.; 6 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.; 7 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.; 8 Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, Ludwig-Maximilian University.
© Georg Thieme Verlag KG Stuttgart · New York.

Abstract

OBJECTIVE:The aim of this study was a retrospective analysis of clinical manifestation and treatment outcome of the nasal form of transmissible venereal tumours (TVT).
MATERIAL AND METHODS:Twelve dogs suffering from nasal TVT were included in this study. Patients with primary genital lesions were excluded from the study. Signalment, physical examination and laboratory findings, results of further diagnostics, and treatment results were recorded in all patients.
RESULTS:The study population comprised 9 male and 4 female dogs with an (estimated) age ranging from 3 to 7 years. With one exception all dogs originated from Ukraine. Symptoms of nasal TVT included sneezing, nasal bleeding (all cases), skull infiltration (9 cases), oronasal fistulas (9 cases) and cutaneous fistulas (5 cases). Animals received vincristine sulfate at 0.7 mg/m2 i. v. weekly. The treatment course consisted of 4-9 cycles (median 5 cycles). Complete remission was achieved in all cases. All dogs were disease-free during the follow-up period (median 23.5 months, range 12-56 months). All patients tolerated the treatment very well.
CLINICAL SIGNIFICANCE:In conclusion, our data suggest that nasal TVT can have a good response to vincristine treatment. TVT should be considered as a differential diagnosis in sneezing dogs with nasal discharge or bleeding especially in young dogs and in dogs with suspected nasal tumours, even in countries without a stray animal population.

PubMed Other Abstract

ZIEL: Das Ziel dieser Studie war, die klinische Manifestation der nasalen Form des transmissiblen venerischen Tumors (TVT, Sticker-Sarkom) und die Wirksamkeit einer Therapie mit Vincristin retrospektiv zu analysieren.
MATERIAL UND METHODEN:In die Studie wurden 12 Hunde mit einem nasalen TVT einbezogen. Patienten mit primären Genitalläsionen blieben von der Studie ausgeschlossen. Die Auswertung erstreckte sich auf Signalement der Hunde, klinische und labordiagnostische Befunde, Befunde weiterführender Diagnostik sowie Ansprechen auf die Behandlung.
ERGEBNISSE:Bei den Patienten handelte es sich um 9 Rüden und 4 Hündinnen im (geschätzten) Alter von 3–7 Jahren, die mit einer Ausnahme aus der Ukraine stammten. Die Symptome waren Niesen, Nasenbluten (n = 12), Infiltration des Schädels (n = 9), oronasale Fisteln (n = 9) und Hautfisteln (n = 5). Die Tiere erhielten Vincristinsulfat 0,7 mg/m2 i. v. wöchentlich in 4–9 Sitzungen (Median 5 Sitzungen). In allen Fällen wurde eine vollständige Remission erreicht und keiner der Hunde zeigte in der Nachbeobachtungszeit (Median 23,5 Monate, Bereich 12–56 Monate) Symptome des TVT. Alle Patienten vertrugen die Behandlung sehr gut.
SCHLUSSFOLGERUNG:Den Ergebnissen zufolge spricht der TVT gut auf eine Behandlung mit Vincristin an. Diese Neoplasie sollte bei niesenden Hunden mit Nasenausfluss, nasalen Blutungen und Gesichtsdeformationen differenzialdiagnostisch Berücksichtigung finden. Dies gilt insbesondere für junge Tiere mit Verdacht auf Nasentumoren, auch wenn diese nicht aus Ländern mit streunenden Hunden stammen.

Article Tools:
   Medline
   Email to me

Archives Highlights:
Mass rabies exposure of veterinary health care workers in Germany: Management, immune response, and tolerability of post exposure-prophylaxis.
In 2008, Germany was declared free from terrestrial rabies by the WOAH. However, illegal pet imports can still lead to rabies exposure, as seen in the 2021 case of a rabid puppy illegally imported to Germany, resulting in a mass exposure (39 veterinary clinic staff) incident.
Investigating the Reasons behind Companion Animal Relinquishment: A Systematic Content Analysis of Shelter Records for Cats and Dogs, 2018-2023.
The most frequent reasons cited were Behavior Issues (28%), Housing/Moving (18%), Unable to Care (16%), Too Many Pets (10%), Financial (6%), and Owner Allergies (5%). The most common behavioral reasons reported were Aggression (32% of behavioral surrenders), Social Conflict (28%), and Soiling (13%).
Cryptorchidism in dogs and cats presented for elective gonadectomy: A descriptive cohort study of 306 animals treated between 2018 and 2023.
5,476 dogs and 11,559 cats were presented to the same facility for elective surgical castration, suggesting a cryptorchid incidence of 3.21 % for dogs and 1.12 % for cats. Cryptorchid testes were more commonly observed in the inguinal area than in the abdomen, and were more frequently located unilaterally on the right side in both dogs and cats.
Efficacy, safety and interval from end of treatment to estrus in cats treated with an ultra-low dose megestrol acetate protocol for suppression of reproductive activity.
Twenty-eight queens were treated orally with 11.5 µg/kg/day of megestrol acetate (MA) for one to six months. MA suppressed reproductive function effectively in 27/28 queens. Transient mammary and uterine hyperplasia were detected in four (14 %) and three (11 %) queens, respectively, treated for more than four months, without associated clinical signs. Significant but reversible weight gain was observed in 85 % of the animals. The resumption of cyclicity occurred on average 6 weeks after the end of treatment but was influenced by the duration of treatment and seasonality.
[Disease Caused by Filoviruses: An Update].
The Marburg and Ebola viruses belong to the Filoviridae family and are known to cause emerging zoonotic diseases. These viruses have a high case fatality rate and are easily transmissible from person to person, which makes them capable of triggering outbreaks, including in non-endemic regions, and are also considered agents of bioterrorism. This review aims to improve clinical knowledge and the approach to suspected cases of FD. Improved surveillance and preparedness for potential global outbreaks are essential measures to effectively respond to these public health threats and to ensure that healthcare professionals are well-informed and prepared to deal with these diseases.

Back Print Save Bookmark in my Browser Email this article to me. Top of Page. VSPN AOW : Nasal transmissible vener...
Contact Us